Dry mouth was the most commonly reported adverse event ( AE ) in the fesoterodine groups ( placebo group , @ % ; fesoterodine @-mg group , @ % ; fesoterodine @-mg group , @ % ) ; most cases were mild or moderate in all treatment groups .